Oxford coronavirus vaccine trials reportedly produce robust immune response in elderly people

Some hope for those most vulnerable to the coronavirus

Vaccine

According to two people familiar with the finding, the Oxford coronavirus vaccine has produced a robust immune response in elderly people, FT reports.

That echoes findings from earlier data, which showed that the vaccine has had a positive response in a group of healthy adults aged between 18 and 55.

The latest development is said to likely be published in a clinical journal shortly.

That said, a positive immunogenecity test does not guarantee that the vaccine will ultimately prove to be safe and/or effective in older people. Such a conclusion will not be known until the full trial data for the age group has been analysed.

The full report by the FT can be found here (may be gated).

I guess that's some hopeful optimism but until we get much closer to the day a safe and effective vaccine is developed, this is just what it is - hope.

investingLive Premium
Telegram Community
Gain Access